Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US2307701092
Ticker CPIX
Company CUMBERLAND PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0000
Recommendation STRONG SELL
P/E 387.17
ROE 0.40 %
Capitalization 85,565,005 $
Dividend Yield 0.00 %
P/S 2.10
AII Position 730
P/E Position 718
ROE Position 725
Capitalization Position 728
Dividend Yield Position 597
Sales 40,742,000 $
10-Year Average Earnings 221,000 $
Shares Outstanding 15,614,052
Equity 55,571,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
CUMBERLAND PHARMACEUTICALS Investor Relations Web Site http://investor.shareholder.com/cpix/index.cfm







Sales:

YEAR MONTH AMOUNT
2018 12 40,742,000.00 $
2017 12 41,150,000.00 $
2016 12 33,026,000.00 $
2015 12 33,519,000.00 $
2014 12 36,901,000.00 $
2013 12 32,027,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -6,963,000.00 $
2017 12 -7,979,000.00 $
2016 12 -945,000.00 $
2015 12 731,000.00 $
2014 12 2,423,000.00 $
2013 12 -2,105,000.00 $
2012 12 5,842,000.00 $
2011 12 5,658,000.00 $
2010 12 2,457,000.00 $
2009 12 3,091,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 55,571,000.00 $
2017 12 63,922,000.00 $
2016 12 73,121,000.00 $
2015 12 76,820,000.00 $
2014 12 80,752,791.00 $
2013 12 79,292,000.00 $
2012 12 85,566,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 15,614,052
2017 12 15,911,577
2016 12 16,236,525
2015 12 17,094,754
2014 12 17,899,632
2013 12 18,332,997
2012 12 19,787,537

 












Bloomberg News for CUMBERLAND PHARMACEUTICALS:



Google News for CUMBERLAND PHARMACEUTICALS:

GCR - 2 days ago
Cumberland Pharmaceuticals (NASDAQ:CPIX) Announces ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) released its earnings results on Tuesday. The specialty pharmaceutical company reported ...
Riverton Roll
Cumberland Pharmaceuticals (CPIX) Misses Q3 Earnings and ...
Cumberland Pharmaceuticals (CPIX) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.11 per ...
Today Israel (press release)
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Receives ...
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that ...
Yahoo Finance - 4 days ago
Cumberland Pharmaceuticals' (CPIX) CEO AJ Kazimi on Q3 2019 ...
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET. Company ...
NCTY News - 23 hours ago
Cumberland Pharmaceuticals (CPIX) Dips More Than Broader ...
In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $5.56, marking a -0.18% move from the previous day. This change ...
Trent Times
Do Insiders Own Shares In Cumberland Pharmaceuticals Inc ...
The big shareholder groups in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) have power over the company. Generally speaking, as a ...
Slater Sentinel
Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains ...
Cumberland Pharmaceuticals (CPIX) closed the most recent trading day at $5.34, moving +0.75% from the previous trading session. The stock ...
Seeking Alpha - 4 days ago
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Institutional ...
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) institutional sentiment increased to 1.43 in 2019 Q2. Its up 0.79, from 0.64 in 2019Q1.
P&T Community
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Quarterly ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) released its quarterly earnings results on Tuesday. The specialty pharmaceutical company ...
Merakhaber News
Cumberland Pharmaceuticals To Announce Third Quarter 2019 ...
NASHVILLE, Tenn., Nov. 5, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third ...


Back